Literature DB >> 29511843

PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.

James T Thackeray1.   

Abstract

PURPOSE OF REVIEW: Local inflammation after myocardial infarction (MI) plays a role in subsequent ventricular remodeling, influences cardiac outcome, and has emerged as a therapeutic target. Preclinical and clinical PET imaging studies have employed a variety of radiotracers to target inflammatory leukocytes in the early stages after MI. RECENT
FINDINGS: Imaging of enhanced metabolism in activated macrophages with 18F-FDG is feasible and has been associated with cardiac outcome in a small prospective study. Novel targeted PET agents show higher specificity for inflammatory leukocytes and can identify therapeutic response with limited background. While PET imaging of acute inflammation after MI has grown in recent years, significant challenges remain to widespread clinical application, including the complex cellular composition of the imaging signal and unclear association with functional outcome. Future studies must address the prognostic value of post-MI inflammation imaging and the ability to discern response to targeted, expensive, and personalized therapies.

Entities:  

Keywords:  18F-deoxyglucose; Inflammation; Leukocytes; Macrophages; Molecular imaging; Myocardial infarction

Mesh:

Substances:

Year:  2018        PMID: 29511843     DOI: 10.1007/s11886-018-0955-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  52 in total

1.  Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography.

Authors:  Oliver Gaemperli; Joseph Shalhoub; David R J Owen; Frederic Lamare; Saga Johansson; Naghmeh Fouladi; Alun H Davies; Ornella E Rimoldi; Paolo G Camici
Journal:  Eur Heart J       Date:  2011-09-19       Impact factor: 29.983

2.  Peptide receptor-targeted radionuclide therapy alters inflammation in atherosclerotic plaques.

Authors:  Imke Schatka; Tim Wollenweber; Cathleen Haense; Friederike Brunz; Klaus F Gratz; Frank M Bengel
Journal:  J Am Coll Cardiol       Date:  2013-09-25       Impact factor: 24.094

3.  Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings.

Authors:  Ryogo Minamimoto; Miyako Morooka; Kazuo Kubota; Kimiteru Ito; Yoko Masuda-Miyata; Takuya Mitsumoto; Risen Hirai; Osamu Okazaki; Michiaki Hiroe
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

4.  PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.

Authors:  Ambros J Beer; Jaroslav Pelisek; Peter Heider; Antti Saraste; Christian Reeps; Stephan Metz; Stefan Seidl; Horst Kessler; Hans-Jürgen Wester; Hans Henning Eckstein; Markus Schwaiger
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

5.  Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.

Authors:  John Terrovitis; Riikka Lautamäki; Michael Bonios; James Fox; James M Engles; Jianhua Yu; Michelle K Leppo; Martin G Pomper; Richard L Wahl; Jurgen Seidel; Benjamin M Tsui; Frank M Bengel; M Roselle Abraham; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

6.  Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction.

Authors:  James T Thackeray; Thorsten Derlin; Arash Haghikia; L Christian Napp; Yong Wang; Tobias L Ross; Andreas Schäfer; Jochen Tillmanns; Hans J Wester; Kai C Wollert; Johann Bauersachs; Frank M Bengel
Journal:  JACC Cardiovasc Imaging       Date:  2015-11-11

7.  Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.

Authors:  Iina Laitinen; Antti Saraste; Eliane Weidl; Thorsten Poethko; Axel W Weber; Stephan G Nekolla; Pia Leppänen; Seppo Ylä-Herttuala; Gabriele Hölzlwimmer; Axel Walch; Irene Esposito; Hans-Jürgen Wester; Juhani Knuuti; Markus Schwaiger
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-13       Impact factor: 7.792

8.  Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.

Authors:  Edmund J Keliher; Yu-Xiang Ye; Gregory R Wojtkiewicz; Aaron D Aguirre; Benoit Tricot; Max L Senders; Hannah Groenen; Francois Fay; Carlos Perez-Medina; Claudia Calcagno; Giuseppe Carlucci; Thomas Reiner; Yuan Sun; Gabriel Courties; Yoshiko Iwamoto; Hye-Yeong Kim; Cuihua Wang; John W Chen; Filip K Swirski; Hsiao-Ying Wey; Jacob Hooker; Zahi A Fayad; Willem J M Mulder; Ralph Weissleder; Matthias Nahrendorf
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

9.  Cre/lox-assisted non-invasive in vivo tracking of specific cell populations by positron emission tomography.

Authors:  Martin Thunemann; Barbara F Schörg; Susanne Feil; Yun Lin; Jakob Voelkl; Matthias Golla; Angelos Vachaviolos; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Marcus Olbrich; Walter Ehrlichmann; Gerald Reischl; Christoph M Griessinger; Harald F Langer; Meinrad Gawaz; Florian Lang; Michael Schäfers; Manfred Kneilling; Bernd J Pichler; Robert Feil
Journal:  Nat Commun       Date:  2017-09-05       Impact factor: 14.919

10.  Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus.

Authors:  Neil Ruparelia; Janet E Digby; Andrew Jefferson; Debra J Medway; Stefan Neubauer; Craig A Lygate; Robin P Choudhury
Journal:  Inflamm Res       Date:  2013-03-08       Impact factor: 4.575

View more
  1 in total

1.  Inhibition of miR-182-5p attenuates ROS and protects against myocardial ischemia-reperfusion injury by targeting STK17A.

Authors:  Xia Li; Yalei Jin
Journal:  Cell Cycle       Date:  2022-05-03       Impact factor: 5.173

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.